IPO Profile: Adamas Pharmaceuticals Inc
Aeris Capital, DAG Ventures, Mohr Davidow Ventures and Northgate Capital as a group own about 9.24 million shares worth $147.8 million at the IPO price.
1 May 2014•1 min read
Aeris Capital, DAG Ventures, Mohr Davidow Ventures and Northgate Capital as a group own about 9.24 million shares worth $147.8 million at the IPO price.
